Methylstenbolone or MSten is a mass-building prohormone that helps users gain size and strength without sacrificing definition. M Sten is derived from DHT, so it doesn’t convert to estrogen, resulting in little to no water retention.
Methylstenbolone is methylated, so liver toxicity is associated with this compound. Taking a Cycle Support product can help minimize or eliminate the potential for side effects while on cycle.
Following a healthy diet, training intensely, and proper use of MSten can result in gains of 5-20 lbs of lean muscle mass during a cycle.
What are the benefits of Methylstenbolone:
Size Gains
Mass Gains
Strength Gains
Zero Conversion to Estrogen
Muscle Density Increase
What are the side effects of Methylstenbolone:
Liver Toxicity
Increased Blood Pressure
Back Acne
Headaches
Mood Swings
Lethargy
Aggression
Recommended Dose/Cycle
A typical cycle of Methylstenbolone should last 4 weeks for normal users. Advanced users may extend their cycles, but should start with lower doses.
Beginner & Intermediate Users:
Week 1: 4-8mg per day with proper liver care and cycle support
Week 2-3: 8mg per day with proper liver care and cycle support
Advanced Users:
Week 1: 8mg per day with proper liver care and cycle support
Week 2-3: 12mg per day with proper liver care and cycle support
Week 4: 16mg per day with proper liver care and cycle support
Do I Need Cycle Support:
Yes. A cycle support is always recommended during prohormone cycles, especially with methylated products.
Cycle Support helps minimize side effects. If you experience issues with back acne, try using Taurine.
Regulates Hormone Levels
Supports Prostate Health
Lowers Blood Pressure
Protects Liver and Kidney
Improves Immune Function
Enhances Mood
Do I Need A Post Cycle Therapy:
Always. Post Cycle Therapy helps restore natural testosterone levels. It helps to lock in those hard-fought gains you made.
Restores Natural Testosterone Levels
Detoxifies Your Body
Increases Libido
Improves Immune Function
Helps Prevent Side Effects
Reviews
There are no reviews yet.